<--- Back to Details
First PageDocument Content
GlaxoSmithKline / Organofluorides / Respiratory therapy / Pharmacology / Fluticasone propionate / Fluticasone furoate / Rhinitis / Nasal spray / Pharmaceutical drug / Medicine / Pulmonology / Glucocorticoids
Date: 2013-07-12 14:26:37
GlaxoSmithKline
Organofluorides
Respiratory therapy
Pharmacology
Fluticasone propionate
Fluticasone furoate
Rhinitis
Nasal spray
Pharmaceutical drug
Medicine
Pulmonology
Glucocorticoids

Summary Basis of Decision Avamys

Add to Reading List

Source URL: hc-sc.gc.ca

Download Document from Source Website

File Size: 72,36 KB

Share Document on Facebook

Similar Documents

Alabama State Board of Respiratory Therapy P. O. Box, Montgomery, ALPhone: CHANGE OF INFORMATION NOTICE Current Licensee Information on file:

DocID: 1v1Mc - View Document

Alabama State Board of Respiratory Therapy P. O. Box, Montgomery, ALPhone: Fax: Web Site: www.asbrt.alabama.gov Application for a

DocID: 1uPF5 - View Document

Respiratory Therapy           1 RESPIRATORY THERAPY Associate of Applied Science Admission Procedures Program Description:

DocID: 1tK8P - View Document

RESPIRATORY THERAPY Associate of Applied Science Students are admitted to South Texas College through the provisions of Board PolicyGeneral admission to the College does not imply admission to all progra

DocID: 1sR0Q - View Document

TIMED MODEL OF THE RADIATION THERAPY SYSTEM WITH RESPIRATORY MOTION COMPENSATION Tomas KRILAVIČIUS *, KA LOK MAN ** *Vytautas Magnus university and Baltic Institute of Advanced Technologies; ** Xi’an Jiaotong-Liverpoo

DocID: 1sx7R - View Document